Chanelle Group annually allocates considerable resources and funds to a continuous and extensive R&D programme in order to ultimately licence veterinary products and increase its presence in the animal health market.
Chanelle Chemicals Limited is the Research and Development Company within the group and is responsible for the development of synthetic processes for active drug substances from the laboratory stage, through pilot plant stage to commercial production. These processes are broken down as follows:
- Product Synthesis: Developed the synthesis of 6 molecules
- Formulation Development: solutions, suspensions, powder, tablets & capsules including slow release formulations
- Analytical Development and Validation
- Stability Studies: including Protocols according to ICH Guidelines
- Registration Dossiers
- Bio equivalence Studies
- Process Validation
- Consultancy Service
The R&D activity is coordinated by highly competent staff engaged in studies and experiments pertaining to the safety and efficacy of Chanelle products.
The Registration of any new product incorporates the generation of detailed pharmacological, toxicological, safety and efficacy data for the product. Pharmaceutical development has to be carried out in each of the intended target species, due to species variation.